Biomarker Brings Hope

Scientists have discovered a new way to identify people at risk of chronic obstructive pulmonary disease (COPD). This significant finding could lead to earlier detection of the progressive lung disease and ultimately transform how patients are treated.

Researchers from the Centre for Heart Lung Innovation at St. Paul’s Hospital, in collaboration with partners, found a novel non-invasive imaging biological marker, or “biomarker,” that detects damage to the small airways.

The team hopes this biomarker will provide a way to identify patients who are likely to progress to symptomatic lung disease before they can be diagnosed using traditional methods.